<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
FRLN
Freeline
$
()


  • Acquisition of Freeline by Syncona becomes effective

    2/20/2024 - 07:10am
  • Freeline shareholders approve acquisition by Syncona

    2/12/2024 - 12:01pm
  • Freeline downgraded to Neutral from Buy at H.C. Wainwright

    11/28/2023 - 06:06am
  • Freeline enters agreement to be acquired by Syncona

    11/22/2023 - 07:33am
  • Freeline Therapeutics Holdings PLC (ADR) trading resumes

    11/6/2023 - 10:13am
  • Freeline Therapeutics Holdings PLC (ADR) trading halted, volatility trading pause

    11/6/2023 - 10:03am
  • Freeline announces new data from GALILEO-1 trial of FLT201

    10/25/2023 - 05:45am
  • Freeline downgraded to Neutral from Outperform at Wedbush

    10/18/2023 - 08:11am
  • Freeline to present new clinical data for FLT201 at ESGCT Congress

    10/16/2023 - 07:12am
  • Stifel keeps Hold on Freeline despite positive Phase 1/2 GALILEO-1 update

    10/4/2023 - 11:37am
  • Freeline reports initial data from first cohort of Phase 1/2 GALILEO-1 trial

    10/4/2023 - 07:04am
  • Freeline price target raised to $4 from $3 at Stifel

    8/16/2023 - 07:17am
  • Freeline expects initial clinical data from GALILEO-1 trial in Q3

    8/15/2023 - 07:04am
  • Freeline expects cash to fund operations into 2Q24

    8/15/2023 - 07:03am
  • Freeline reports 1H EPS (23c) vs. (95c) last year

    8/15/2023 - 07:02am
dynamic_feed Breaking News